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Patient and surgical prognostic factors for
inpatient functional recovery following THA
and TKA: a prospective cohort study
Nicola A. Hewlett-Smith1,2* , Rodney P. Pope1,3 , Wayne A. Hing1 , Vini P. Simas1 and James W. Furness1
Abstract
Background: The introduction of enhanced recovery pathways has demonstrated both patient and organisational
benefits. However, enhanced recovery pathways implemented for total hip arthroplasty (THA) and total knee
arthroplasty (TKA) vary between health-care organisations, as do their measures of success, particularly patient-
related outcomes. Despite inpatient functional recovery being essential for safe and timely hospital discharge, there
is currently no gold standard method for its assessment, and the research undertaken to establish prognostic
factors is limited. This study aimed to identify prognostic factors and subsequently develop prognostic models for
inpatient functional recovery following primary, unilateral THA and TKA; identify factors associated with acute
length of stay; and assess the relationships between inpatient function and longer-term functional outcomes.
Methods: Correlation and multiple regression analyses were used to determine prognostic factors for functional
recovery (assessed using the modified Iowa Level of Assistance Scale on day 2 post-operatively) in a prospective
cohort study of 354 patients following primary, unilateral THA or TKA.
Results: For the overall cohort and TKA group, significant prognostic factors included age, sex, pre-operative general
health, pre-operative function, and use of general anaesthesia, local infiltration analgesia, and patient-controlled analgesia.
In addition, arthroplasty site was a prognostic factor for the overall cohort, and surgery duration was prognostic for the
TKA group. For the THA group, significant prognostic factors included pre-operative function, Risk Assessment and
Prediction Tool score, and surgical approach. Several factors were associated with acute hospital length of stay. Inpatient
function was positively correlated with functional outcomes assessed at 6months post-operatively.
Conclusions: Prognostic models may facilitate the prediction of inpatient flow thus optimising organisational efficiency.
Surgical prognostic factors warrant consideration as potential key elements in enhanced recovery pathways, associated
with early post-operative functional recovery. Standardised measures of inpatient function serve to evaluate patient-
centred outcomes and facilitate the benchmarking and improvement of enhanced recovery pathways.
Keywords: Total hip arthroplasty, Total knee arthroplasty, Prognostic factors, Predictors, Inpatient function, Functional
recovery
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Background
The rising prevalence of osteoarthritis, in Australia and
other developed countries, has seen a corresponding rise
in primary total hip arthroplasty (THA) and primary
total knee arthroplasty (TKA) over the past two decades
[1]. Since its inception in 2003, the Australian National
Joint Replacement Registry has reported an increase in
primary THA and TKA procedures of 108.1% and
156.2% respectively [2]. The increasing burden of these
elective procedures has implications for health care costs
and resources [1]; therefore, efficient provision of quality
patient care is a priority. As such, enhanced recovery
pathways (ERP) have been applied to several surgical
procedures, including THA and TKA, to improve and
streamline the delivery of patient care and reduce hos-
pital length of stay (LOS).
Initially described by Kehlet [3], ERP aim to prepare
patients for surgery, reduce the negative impact of sur-
gery, and facilitate a more rapid recovery. Every step of
the surgical journey, pre-operatively to post-operatively,
is examined, rationalised, optimised, and standardised,
resulting in a streamlined care pathway combining
evidence-based clinical features with optimal organisa-
tional efficiency [4].
Although components of THA and TKA ERP have
been identified, and recommendations put forward, the
level of evidence supporting each of these recommenda-
tions is variable [5]. Currently, no standardised guide-
lines apply to each ERP component, which would more
readily facilitate implementation [6]. The lack of defined
guidelines, and the numerous components that ERP
contain, means that successful implementation requires
multidisciplinary consensus at an organisational level
[6]. Achieving consensus to enable a standardised ap-
proach for each ERP component may prove challenging
in many healthcare facilities. ERP literature reviews have
suggested that future research should focus on under-
standing which pathway components contribute to im-
proved recovery [7] and quantifying the impact of
individual variables [8]. An understanding of which vari-
ables are most associated with early post-operative func-
tional recovery may direct attention to particular pathway
components, thus further improving ERP outcomes.
A recent systematic review [9] examined the prognos-
tic relationships between patient and surgical factors and
early post-operative functional recovery assessed using
validated outcome measures. The review found strong
evidence that comorbidity status (determined by Ameri-
can Society of Anaesthesiologists, ASA grade) and pre-
operative function (assessed by the Timed Up and Go
test, TUG) are prognostic for inpatient functional recov-
ery following TKA. No such evidence was found for
patient-related prognostic factors for inpatient recovery
following THA, and no surgical factors were found to be
independently prognostic for inpatient recovery follow-
ing either procedure. However, limited evidence did sug-
gest ERP may facilitate functional recovery in the TKA
population. None of the studies included in the review
collected data within the last 5 years, and therefore, the
potential impacts of more recent surgical advances in-
cluding muscle-sparing approaches and robot-assisted
surgery were not assessed.
Thus, the primary aims of this study were to examine
the relationships between patient-related and surgical
factors and inpatient functional recovery following THA
and TKA, where functional recovery was assessed using
validated functional performance measures appropriate
to the early post-operative period, and, based on these
findings, to develop prognostic models for inpatient
functional recovery. Secondary aims were to identify
patient-related, surgical, or post-operative factors associ-
ated with acute hospital LOS and to assess the relation-
ships between functional performance measures assessed
on the 2nd post-operative day (POD) and longer-term
(6-month) patient-reported functional outcomes follow-
ing THA and TKA.
Methods
Research design and setting
This prospective cohort study was conducted at The
Wesley Hospital, Brisbane, an Australian privately
funded, not for profit hospital. The ERP applied to this
patient cohort is partially standardised, allowing for indi-
vidual preferences of surgeons and anaesthetists. Ethics
approval was obtained for this study from the Uniting
Care Human Research Ethics Committee (HREC no.
2016.09.187) and Bond University Human Research
Ethics Committee (HREC no. 15685).
Participants
All patients undergoing elective, primary, unilateral
THA and TKA between 1 May 2018 and 30 April 2019
were considered for inclusion. Potential participants
were provided with information about the study for con-
sideration prior to their attendance at pre-admission
clinic, where eligibility criteria were applied and written
informed consent was obtained. Patients were excluded
if they were undergoing uni-compartmental, bilateral, or
revision arthroplasty; not reviewed pre-operatively or
unable to perform the assessments of pre-operative
function; considered inappropriate to participate in the
existing ERP due to multiple complex comorbidities; or
identified to have significant language or cognitive bar-
riers. A two-stage screening process was used to confirm
adequate cognitive function (Appendix 1). The first stage
involved verbal screening in the pre-admission clinic by
an occupational therapist, and a Mini-Mental State
Examination (MMSE) [10] was performed for any
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potential participants who reported difficulty with mem-
ory or cognition. Secondly, an MMSE was undertaken
for any participants whom the treating physiotherapist
observed poor recall or carry-over between treatment
sessions, which appeared to be limiting post-operative
progression. The exclusion criteria were devised to en-
sure homogeneity of participants with regard to pre-
operative education and surgical procedure and to ex-
clude patients with factors reasonably considered to in-
fluence their ability to follow usual instruction or
participate in the usual post-operative physiotherapy
care as part of the existing ERP. All patients received
usual pre-operative and post-operative care regardless of
their participation in the study, with the only difference
being that data pertaining to the potential prognostic
factors were extracted from the medical charts of
participants.
Prognostic factors
Patient-related factors (Table 2) and potentially modifi-
able peri-operative and post-operative factors (Table 3)
associated with the existing ERP were selected as the po-
tential prognostic factors to be investigated.
Outcome measures
Primary outcome measure
The primary outcome measure was inpatient functional
recovery assessed on POD 2 using the modified Iowa
Level of Assistance Scale (mILAS) [11]. The mILAS
(Appendix 2) is an easily performed 6-item functional
performance measure that assesses 4 activities of daily
living (ADL; supine to sitting, sit to stand, walking,
and negotiation of a single step), walking distance,
and required mobility aid. Each item is scored 0–6,
with a maximum possible total score of 36; higher
scores indicate greater functional dependence. The
mILAS has demonstrated validity in assessing readi-
ness for discharge, with a statistically significant dif-
ference in median scores of 17 points observed
between patients considered ready for discharge (me-
dian score 0, IQR 0–4.25) and those deemed not yet
ready for discharge (median score 17, IQR 12–23)
[11]. The mILAS is responsive, with a minimal de-
tectable change (MDC) of 5.8 points and large
changes in scores typically evident over the course of
an acute hospital admission; furthermore, it has excel-
lent inter-rater reliability (intraclass correlation coeffi-
cient; ICC = 0.975) [11].
Secondary outcome measures
Timed Up and Go test, 10-metre walk test POD 2 in-
patient functional recovery was also assessed using the
Timed Up and Go (TUG) test [12] and 10-metre walk
test (10mWT) [13]. The TUG is a reliable test of func-
tional mobility in patients following TKA, with excellent
test-retest reliability (ICC = 0.98) and a MDC of 2.27 s
[14], and has been demonstrated to predict both short-
term [15, 16] and long-term function following lower
limb arthroplasty [17, 18]. The 10mWT is a reliable
measure of gait speed [19]. For both the TUG and
10mWT, a higher score (in seconds) indicates a slower
gait speed, and each is an independent predictor of gen-
eral health decline, ADL difficulty, and falls, in older
community-dwelling adults [20].
Longer-term functional outcomes Longer-term func-
tional outcomes were assessed using patient-reported
outcome measures (PROM), including the Oxford Hip
Score (OHS) [21] or Oxford Knee Score (OKS) [22], and
the EuroQol-5 Dimension visual analogue scale (EQ-5D
VAS) [23], each administered by telephone. The OHS
and OKS are joint-specific PROM designed to assess
pain behaviour and ability to perform ADL following
THA and TKA, with higher scores indicating greater
function [24]. The OHS and OKS have undergone ex-
tensive reliability and validity testing [24] and have been
used in multiple studies, to benchmark arthroplasty out-
comes in the UK and Australian National Joint Replace-
ment Registries. The minimal important changes (MIC)
for assessment at the group level are 11 and 9 points for
the OHS and OKS, respectively [25]. For assessment of
individual patients, the MIC are 8 and 7 points for the
OHS and OKS, respectively [25]. The distribution-based
minimal detectable change (MDC90) estimates were 5
and 4 points, for the OHS and OKS, respectively [25].
The English language versions, adapted for use in
Australia, were used in this study, and scoring was
undertaken per the respective user guides [26, 27].
The EQ-5D-5L is a widely used PROM designed to
provide a simple, generic measure of health [23]. The
VAS component comprises a 20-cm vertical scale num-
bered from 0 to 100, 0 indicating “the worst health you
can imagine” and 100 “the best health you can imagine”.
Participants scoring less than 100 were asked to identify
the aspect of their health responsible for generating the
response. This was in order to distinguish whether the
site of arthroplasty (or another aspect of general health)
was the primary factor impacting their score on the EQ-
5D VAS. It has previously been demonstrated that TKA
functional outcomes measured using the OKS at 12
months post-operatively [28] were influenced by post-
operative general physical health. As such, the EQ-5D
VAS was used to assess general health as a potential
contributor to functional outcomes of the participants.
Length of stay Length of stay (LOS) was calculated as
the number of nights spent in the acute hospital setting.
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Despite previous studies indicating that LOS is influ-
enced by many factors other than the physical function
of the patient [29–34], LOS remains a commonly used
outcome measure for evaluating the success of ERP and
benchmarking performance amongst healthcare organi-
sations and thus was recorded for completeness.
Procedure
All participants underwent primary, unilateral TKA or
THA procedures and received usual pre- and post-
operative care in The Wesley Hospital, consistent with
the existing ERP, under the direction of their treating
surgeon and independent of the research. Usual physio-
therapy care involved day of surgery (DOS) mobilisation
(as appropriate), bidaily physiotherapy on POD 1–3 (in-
cluding weekends), and daily physiotherapy on subse-
quent days (at the discretion of the treating
physiotherapist) until time of discharge or transfer to in-
patient rehabilitation. Physiotherapy incorporated range
of motion and strengthening exercises, transfer practice,
gait re-education, progression of mobility aids and dis-
tances walked, stairs practice, and discharge planning.
Assessments of function were undertaken at pre-
determined time points (Table 1). Pre-operative function
was assessed 1–4 weeks pre-operatively during a usual
pre-admission appointment. Assessments of post-
operative function were conducted during usual post-
operative physiotherapy care, on the afternoon of POD
2, and on the morning of discharge from the
orthopaedic ward. The TUG and 10mWT were assessed
at each time point only if the participant was judged to
be able to perform the test safely and independently
(using their customary mobility aid). For both the TUG
and the 10mWT, time was recorded with a stopwatch
(in seconds), and participants were instructed to perform
the tests as quickly as possible, without compromising
their safety. At each time point, two TUG trials were
completed, and the faster of the two times was recorded.
For the 10mWT, only one trial was assessed at each time
point. For the mILAS, participants were scored based on
the same mobility aid they used when performing the
TUG and 10mWT.
A data collection form was devised to record the po-
tential prognostic factors and the results of outcome
measures for each participant. Information was entered
into a secure database, and subsequently, all participants
were de-identified prior to data analysis. Patient factors
were recorded during a pre-operative subjective assess-
ment; surgical and post-operative factors were extracted
from the patient medical chart. Discharge date was re-
corded and defined as the date each participant was dis-
charged from the acute orthopaedic ward to a suitable
home environment or to inpatient rehabilitation. Patient
readiness to discharge home was mutually determined
by the patient and treating surgeon, with guidance from
the treating physiotherapist based on ERP discharge
criteria (Appendix 3) and independent of the research.
Admission to inpatient rehabilitation was based on con-
sideration of patients’ post-operative medical or func-
tional status and availability of appropriate social
support, and independent of the research.
Data collection and assessment of all outcome mea-
sures were conducted by qualified physiotherapy staff. If
participants were unable to perform any of the func-
tional assessments at a particular time point (Table 1),
the reason for this was recorded. Longer-term functional
outcomes were assessed via telephone interview at 6
months post-operatively, for participants who comprised
the first half of the study cohort.
Statistical analysis
A recruitment target of 350 participants was planned for
the study, based on power calculations conducted using
G*Power software (version 3.1.9.2, 2014). This number
of participants allowed sufficient numbers to ensure stat-
istical power of at least 80% to detect small to moderate
levels of association between the prognostic factors of
interest and the primary outcome measure, if such
existed in the underlying population, using multiple
linear regression analyses and a significance level of
0.05.
All statistical analyses were conducted using SPSS
(IBM, version 26, 2019). Descriptive analyses were first
Table 1 Time points for assessment of pain and functional
measures
Time point Assessments of pain and function
Pre-admission clinic EuroQol-5 Dimension Visual Analogue
Scale
Oxford Hip or Knee Score
Visual analogue scale
Modified Iowa Level of Assistance Scale
Timed Up and Go
10-metre walk test
Post-operative day 2 Visual analogue scale
Modified Iowa Level of Assistance Scale
Timed Up and Go
10-metre walk test
Day of discharge Visual analogue scale
Modified Iowa Level of Assistance Scale
Timed Up and Go
10-metre walk test
Six months post-operative
(50% of cohort only)
EuroQol-5 Dimension Visual Analogue
Scale
Oxford Hip or Knee Score
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conducted to describe the study cohort and variables of
interest and to identify missing values. Distributions of
all continuous prognostic factors and outcome measures
were assessed, with normality and outliers assessed via
visual inspection of histograms, box plots, and normal
QQ plots, to inform decisions regarding the removal of
outliers and approaches to statistical analysis. Independ-
ent samples t tests, Mann-Whitney U tests, and chi-
square tests were used, as appropriate based on variable
types and distributions, to assess baseline differences be-
tween the two surgical groups (TKA and THA) in
demographics, other prognostic factors, and outcome
measures.
To enable assessment of the linearity or other form of
relationships between continuous prognostic and outcome
variables and so inform decision-making about whether
linear regression analyses would be appropriate to use to
assess prognostic relationships, simple error bar charts
were developed and visually inspected. For this purpose,
continuous prognostic factors were first categorised into
equal intervals, and then, where needed to ensure at least
10 participants in each category, two or more categories at
either or both ends of the range of values for each variable
were collapsed to form single categories.
Where linearity of relationships was evident, correla-
tions between each of the ordinal or continuous prog-
nostic factors and POD 2 mILAS were determined using
Pearson’s and Spearman’s correlation analyses, as appro-
priate. Relationships between each of the nominal (di-
chotomous) prognostic factors and POD 2 mILAS were
assessed using point biserial correlation analyses. Only
prognostic factors that were significantly associated with
POD 2 mILAS at the 0.1 level of statistical significance
were included in subsequent multiple linear regression
analyses. Nominal prognostic factors with sub-groups of
less than 30 participants were also excluded from subse-
quent analyses due to the impacts of small sub-groups
on statistical power to detect associations.
Prior to the conduct of multiple linear regression
modelling, Pearson’s correlation analyses were under-
taken to identify collinearity among continuous prognos-
tic factors. Similarly, point biserial correlation analyses
were undertaken to determine whether any dichotomous
prognostic factors were substantially correlated with the
continuous prognostic factors. Pairs of factors for which
the correlation analyses yielded r > 0.7 were identified,
and in any such instances, one of the two correlated fac-
tors was removed from the subsequent regression ana-
lyses, based on pragmatic considerations which were
recorded. Backward, stepwise, multiple linear regression
analysis was then used to determine the combination of
prognostic factors that best predicted POD 2 mILAS,
with the level of statistical significance set at 0.05 for re-
tention of any prognostic factor in the final regression
model. Regression models were determined in this way
for the whole cohort and separately for each of the THA
and TKA cohorts.
Results
The patient and participant flow through the study is
depicted in Fig. 1.
Descriptive statistics for patient characteristics assessed
pre-operatively are presented in Table 2. Statistically sig-
nificant differences existed between THA and TKA
groups for mean body mass index (BMI) (p = 0.002), ASA
grade distribution (p < 0.001), patient-reported pre-
operative function as determined by mean OHS or OKS
scores (p = 0.02), and mean Risk And Prediction Tool
(RAPT) score (p = 0.03). However, with the exception
of ASA grade distributions, these differences were not
of a sufficient magnitude to be considered clinically
important.
Descriptive statistics for surgical prognostic factors ex-
tracted from medical records are presented in Table 3. A
statistically significant difference was identified between
THA and TKA groups only for anaesthetic method–gen-
eral anaesthetic (GA) only (p = 0.04).
Primary outcome measure
POD 2 mILAS
For the overall cohort, POD 2 mILAS scores ranged
from 0 to 27, with a mean score (± SD) of 11.34 (± 6.2)
points, and there were no missing values. The mean
score for the THA group was 9.85 (± 6.0) and for the
TKA group 12.06 (± 6.1), giving a statistically significant
mean difference between the 2 groups of 2.21 points
(95% CI, 0.85, 3.57), t(352) = 3.187, p = 0.02. Linearity
was established for the relationships between POD 2
mILAS and all continuous and ordinal prognostic fac-
tors. However, following visual inspection of boxplots,
three significant outliers were identified, and these par-
ticipants were removed from further analysis with rea-
sons recorded (Fig. 1). The levels of association between
the individual prognostic factors and POD2 mILAS
scores are presented in Table 4.
BMI, pre-operative pain (VAS), tourniquet duration,
tourniquet pressure, oral analgesia only, TKA surgical
approach, single-shot regional block, and regional block
infusion were excluded from the subsequent regression
analyses as no statistically significant association was
identified between these prognostic factors and POD 2
mILAS scores at the 0.1 level of significance. ASA grade
was not included in the regression model due to too few
case numbers in ASA grades 1 and 4. Instead, Spear-
man’s correlation analysis was used to gauge the
strength of the relationship between ASA grade and
POD 2 mILAS scores, and a weak but statistically signifi-
cant positive correlation (rS = 0.17 (329), p = 0.002) was
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identified. Robot-assisted surgery was removed from
TKA and THA analyses due to too few participants hav-
ing undergone this type of surgery, once the cohort was
split by surgical type. Pre-operative TUG time and pre-
operative 10mWT time were highly correlated, r =
0.880, and so, the prognostic factor pre-operative
10mWT was not included in the subsequent regression
analyses. This decision to remove the 10mWT rather
than TUG from the subsequent regression analyses was
made due to variation within the literature regarding the
methodology of the 10mWT [35], and thus, its imple-
mentation in clinical practice was considered to be po-
tentially less standardised than implementation of the
TUG.
The final regression model for prediction of POD 2
mILAS scores in the overall combined TKA and THA
cohort, based on significant prognostic factors, is
depicted in Table 5, with R2 of 34.7% and adjusted R2 of
33.1%, reflecting a medium effect size [36], and with F(8,
329) = 21.882, p < 0.001. POD 2 mILAS scores (i.e. level
of functional dependence of the patient) increased an
average of 0.20 points for every year of age, after the
other significant prognostic factors were considered
(Table 5). POD 2 mILAS scores were on average 1.67
points higher for females than males and decreased an
average of 0.05 points for every additional point reported
on the EQ-5D VAS general health scale (Table 5). Pre-
operative TUG time was a further significant prognostic
factor, with POD 2 mILAS scores increasing on average
0.45 points for every additional second a patient required
to complete the TUG (Table 5). Among the surgical fac-
tors, arthroplasty site was a significant prognostic factor,
with POD 2 mILAS scores on average 2.21 points higher
in patients who underwent a TKA rather than a THA pro-
cedure (Table 5). POD 2 mILAS scores were on average
2.07 points lower in patients who received general anaes-
thesia (GA) only, when compared to those who received
other forms of anaesthesia (Table 5). Similarly, POD 2
mILAS scores were on average 3.02 points lower in pa-
tients who received local infiltration analgesia (LIA), when
compared to those patients who did not, and POD 2
mILAS scores were on average 2.02 points higher in
Fig. 1 Study flow diagram
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Table 2 Descriptive statistics. Patient characteristics, assessed pre-operatively
Patient characteristic Total cohort, N = 354 TKA, n = 238 (67.2%) THA, n = 116 (32.8%) p value
Age (years), mean (SD) 68.9 (9.2) 69.5 (8.9) 67.7 (9.9) 0.09
Sex, N (%) 0.30
Female 185(52.0%) 129 (54.2%) 56 (48.3%)
Male 169 (48.0%) 109 (45.8%) 60 (51.7%)
BMI (kg/m2)
Median (IQR) 30.0 (26.6, 33.6) 30.3 (27.0, 34.5) 28.4 (26.1, 31.3) 0.002*
Range (18.1–48.8)
Missing: n = 1 (0.3%)
(18.1–48.8) (18.9–45.8)
ASA grade, N (%)
1 27 (8.2%) 12 (5.5%) 15 (13.5%) < 0.001*
2 180 (54.4%) 111 (50.5%) 69 (62.2%)
3 122 (36.9%) 97 (44.1%) 25 (22.5%)
4 2 (0.6%) 0 (0%) 2 (1.8%)
Median (IQR) 2 (2, 3)
Missing: n = 23 (6.5%)
2 (2, 3) 2 (2, 2)
Pre-operative Hb (g/L)
Mean (SD) 137.9 (11.8)
Missing: n = 4 (1.1%)
137.5 (11.6) 138.7 (12.1) 0.40
Pre-operative pain (VAS 0–100) 0.05
Mean (SD) 38.9 (26.3)
Missing: n = 6 (1.7%)
37.0 (26.7) 42.8 (25.0)
Pre-operative function
OKS/OHS (0–48)
Mean (SD) 25.5 (8.0)
Missing: n = 2 (0.6%)
26.0 (8.0) 23.7 (7.9) 0.02*
EQ-5D VAS (0–100)
Median (IQR) 80 (70, 90) 80 (70, 90) 80 (65, 90) 0.11
Range (10–100)
Missing: n = 4 (1.1%)
(10–100) (18–100)
mILAS (0-36)
Median (IQR) 0 (0.0, 0.0) 0 (0.0, 0.0) 0 (0.0, 0.0) 0.16
Range (0–11) (0–11) (0–11)
TUG (s)
Median (IQR) 8.79 (7.41, 11.09) 8.76 (7.58, 11.05) 8.98 (7.17, 11.28) 0.56
Range (4.39–30.93) (4.97–29.29) (4.39–30.93)
10mWT (s)
Median (IQR) 7.61 (6.49, 9.40) 7.65 (6.52, 9.40) 7.58 (6.44, 9.42) 0.71
Range (4.23–27.02) (4.23–22.94) (4.75–27.02)
RAPT score
Mean (SD) 9.48 (2.1)
Missing: n = 5 (1.4%)
9.3 (2.2) 9.8 (2.0) 0.03*
Missing data: was omitted during pre-admission assessment or could not be extracted from patient medical chart
ASA American Society of Anaesthesiologists, BMI body mass index, EQ-5D VAS EuroQol-5 Dimension Visual Analogue Scale, Hb haemaglobin, IQR inter-quartile
range, mILAS modified Iowa Level of Assistance Scale, OKS Oxford Knee Score, OHS Oxford Hip Score, RAPT Risk Assessment and Prediction Tool, THA total hip
arthroplasty, TKA total knee arthroplasty, TUG Timed Up and Go test, VAS visual analogue scale, 10mWT ten-metre walk test
*Statistical significance assessed at the 0.05 level. p values were derived from an independent-samples t-test, Mann-Whitney U test, or chi-square test comparing
TKA and THA cohorts, as appropriate for variable type
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patients who received post-operative analgesia via patient-
controlled analgesia (PCA) when compared to those
patients who did not (Table 5).
The final regression model for prediction of POD 2
mILAS scores in the TKA group, based on significant
prognostic factors, is depicted in Table 6, with R2 of 36.4%
and adjusted R2 of 34.1%, reflecting a medium effect size
[36], and with F(8, 220) = 15.723, p < 0.001. POD 2
mILAS scores increased on average 0.18 points for every
year of age and were on average 1.49 points higher for fe-
males than males (Table 6). POD 2 mILAS scores de-
creased on average 0.09 points for every additional point
reported on the EQ-5D VAS general health scale, and
similarly increased an average of 0.50 points for every add-
itional second a patient required to complete the TUG
(Table 6). POD 2 mILAS scores were on average 2.07
points lower in patients who received a GA only, when
compared to those who received other forms of anaesthe-
sia (Table 6). POD 2 mILAS scores were on average 3.62
points lower in patients who received LIA, when com-
pared to those patients who did not, and POD 2 mILAS
scores were on average 2.35 points higher in patients who
received post-operative analgesia via PCA when compared
to those patients who did not (Table 6). POD 2 mILAS
scores were also on average 0.03 points lower for every
additional minute of surgical time (Table 6).
Table 3 Descriptive statistics. Surgical prognostic factors
Surgical factor Total cohort, N = 354 TKA, n = 238 (67.2%) THA, n = 116 (32.8%) p value
Tourniquet duration N/A
(mean [SD] min) 59.0 (21.5)
n = 231 (missing n = 7)
Tourniquet pressure N/A
(mean [SD] mmHg) 292.5 (29.1)
n = 231 (missing n = 3)
Surgical approach, N (%) N/A
Parapatellar TKA 228 (95.8%)
Subvastus TKA 10 (4.2%)
Posterior approach THA 71 (61.2%)
Direct anterior approach THA 22 (19.0%)
Direct superior approach THA 23 (19.8%)
Robot-assisted surgery, N (%) 0.16
No 318 (89.8%) 210 (88.2%) 108 (93.1%)
Yes 36 (10.2%) 28 (11.8%) 8 (6.9%)
Duration of surgery (min) 0.67
Median (IQR) 79 (70, 93) 79 (71, 91) 79 (67, 100)
Range (37–178) (37–178) (49–167)
Anaesthetic method, N (%)
GA only 97 (27.4%) 57 (23.9%) 40 (34.5%) 0.04*
GA + spinal LA 198 (55.9%) 145 (60.9%) 53 (45.7%) 0.07
Sedation + spinal LA 55 (15.5%) 34 (14.3%) 21 (18.1%) 0.35
Other (intrathecal morphine) 4 (1.1%) 2 (0.8%) 2 (1.7%) N/A
Initial analgesia, N (%)
Intra-operative LIA 294 (83.1%) 214 (89.9%) 80 (69.0%) < 0.001*
PCA 76 (21.5%) 49 (20.6%) 27 (23.3%) 0.56
Oral analgesia only 27 (7.6%) 7 (2.9%) 20 (17.2%) < 0.001*
Intra-articular catheter 113 (47.5%) N/A
Single-shot regional block 31 (13.0%) N/A
Ambulatory regional block 25 (10.5%) N/A
Missing data: could not be extracted from patient medical chart
GA general anaesthesia, IQR inter-quartile range, LA local anaesthesia, LIA local infiltration analgesia, PCA patient-controlled analgesia, THA total hip arthroplasty,
TKA total knee arthroplasty
*Statistical significance assessed at the 0.05 level. p values were derived from an independent-samples t test, Mann-Whitney U test, or chi-square test comparing
TKA and THA cohorts, as appropriate for variable type
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The final regression model for prediction of POD 2
mILAS scores in the THA group, based on significant
prognostic factors, is depicted in Table 7, with R2 of
32.4% and adjusted R2 of 30.4%, reflecting a medium effect
size [36], and with F(3, 105) = 16.742, p < 0.001. POD 2
mILAS scores decreased an average of 0.94 points for
every additional point scored on the RAPT, after the other
significant prognostic factors were considered (Table 7).
POD 2 mILAS scores increased on average 0.36 points for
every additional second a patient required to complete the
TUG (Table 7). THA surgical approach was a further sig-
nificant prognostic factor, with POD 2 mILAS scores on
average 4.67 points higher in patients who underwent
THA via a posterior surgical approach when compared to
other surgical approaches (direct anterior approach or
direct superior approach; Table 7).
Independent samples t tests and chi-square tests re-
vealed no statistically significant differences in age, ASA
grade distributions, or measures of pre-operative function,
between the THA surgical approach groups—posterior
approach (PA) versus direct anterior approach (DAA) or
direct superior approach (DSA).
Additional analyses revealed participants who mobi-
lised on the DOS had lower mean POD 2 mILAS scores
(10.43 ± 5.8) than those who first mobilised on POD 1
(13.64 ± 6.5), with a statistically significant difference of
3.21 points (95% CI, 1.81, 4.61), t(352) = 4.513, p <
0.001. In the overall cohort, 49.2% experienced barriers
to post-operative progress (Table 8). Participants who
experienced post-operative progress barriers had higher
mean POD 2 mILAS scores (14.65 ± 5.5) than those
who did not (8.13 ± 5.0), with a statistically significant
difference of 6.52 points (95% CI, − 7.62, − 5.42), t(352)
= − 11.636, p < 0.001.
Secondary outcome measures
POD 2 TUG and POD2 10mWT
In the overall cohort, 75.7% and 76.3% of participants
completed the POD 2 TUG and 10mWT, respectively.
The reasons for non-completion of these outcome mea-
sures are as follows: 18.1% of the cohort failed to meet an
appropriate level of functional independence, 2.5% were
inadvertently omitted by the treating therapist, and ap-
proximately 3.0% were limited by symptoms including
pain, nausea, dizziness, wound ooze, and diarrohea or
were awaiting investigations. Due to the proportion of
participants for whom this outcome data was missing, re-
gression analyses were not completed for these outcome
measures. However, Spearman’s correlation revealed a
moderate correlation between POD 2 mILAS scores and
scores on each of the secondary outcome measures
assessed on POD 2: POD 2 TUG r(266) = 0.48, p < 0.001,
and POD 2 10mWT r(268) = 0.39, p < 0.001.
Longer-term (6 months) PROMs
As planned, 6 months follow-up and collection of data
pertaining to longer-term outcomes were completed for
Table 4 Correlation between individual potential prognostic
factors and POD 2 mILAS scores
Potential prognostic factors r or rS p value
Patient-related factors
Age 0.34 < 0.001*
Pre-operative Hb − 0.19 < 0.001*
RAPT score − 0.39 < 0.001*
Pre-operative patient-reported function
(OKS/OHS)
− 0.16 < 0.001*
Pre-operative function (mILAS) 0.20 < 0.001*
Pre-operative function (TUG) 0.33 < 0.001*
Pre-operative function (10mWT) 0.34 < 0.001*
Gender (0 = female, 1 = male) − 0.19 < 0.001*
ASA 0.17 0.002*
Pre-operative patient-reported general health
(EQ-5D VAS)
− 0.11 0.04*
Pre-operative pain (VAS) 0.09 0.11
BMI 0.05 0.34
Surgical factors
Surgical approach (THA cohort only)
(0 = PA, 1 = DAA or DSA)
− 0.37 < 0.001*
LIA use − 0.21 < 0.001*
Surgery duration − 0.24 < 0.001*
PCA use 0.18 0.001*
Arthroplasty site (0 = THA, 1 = TKA) 0.17 0.002*
Intra-articular catheter (TKA cohort only) − 0.19 0.003*
GA only − 0.13 0.02*
Sedation and spinal anaesthesia 0.09 0.09*
Robot-assisted surgery − 0.09 0.09*
Single-shot regional block (TKA cohort only) 0.08 0.21
Oral analgesia only 0.06 0.25
GA and spinal anaesthesia 0.03 0.53
Surgical approach (TKA cohort only)
(1 = parapatellar approach, 2 = subvastus approach)
− 0.04 0.54
Ambulatory regional block (TKA cohort only) 0.04 0.57
Tourniquet pressure (TKA cohort only) − 0.02 0.76
Tourniquet duration (TKA cohort only) − 0.02 0.80
ASA American Society of Anaesthesiologists, BMI body mass index, DAA direct
anterior approach, DOS day of surgery, DSA direct superior approach, EQ-5D
VAS EuroQol-5 Dimension Visual Analogue Scale, Hb haemaglobin, GA general
anaesthesia, LIA local infiltration analgesia, mILAS modified Iowa Level of
Assistance Scale, OKS Oxford Knee Score, OHS Oxford Hip Score, PA posterior
approach, PCA patient-controlled analgesia, POD post-operative day, RAPT Risk
Assessment and Prediction Tool, THA total hip arthroplasty, TKA total knee
arthroplasty, TUG Timed Up and Go test, VAS visual analogue scale, 10mWT
ten-metre walk test
*Statistical significance assessed at the 0.1 level. p values were derived from
Pearson’s correlation, Spearman’s correlation, or point biserial correlation, as
appropriate for variable type
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179 (50.6%) of the 354 participants included in the pri-
mary analyses. For this sub-group, the changes between
baseline measures and measures assessed at 6 months
post-operatively are presented in Table 9. The median
increases in OHS and OKS scores for the THA and
TKA sub-groups, respectively, exceeded the group MICs
for these measures of 11 (OHS) and 9 points (OKS) [25]
(Table 9). The OHS MIC, for individuals, of 8 points
[25] was exceeded by 93.3% of the THA sub-group.
Similarly, 82.9% of the TKA sub-group exceeded the
OKS MIC for individuals of 7 points [25] (Table 9). An
increase of only 1 point in the median change score for
the EQ-5D VAS (Table 9) indicated that self-reported
general health status did not differ significantly between
pre-operative assessment and 6months post-operative
assessment for the participants followed up at 6 months
post-operatively.
A small, negative statistically significant correlation
existed between POD 2 mILAS score and OKS or OHS
scores at 6 months post-operatively for the overall sub-
group (r(177) = − 0.27, p < 0.001), and similarly for the
TKA sub-group (r(116) = − 0.19, p = 0.037). A similar
small, negative correlation of borderline statistical
significance was found for the THA sub-group (r(59) =
− 0.25, p = 0.052). The correlation between POD 2
mILAS scores and EQ-5D VAS scores at 6 months post-
operatively did not meet statistical significance for any
of the studied cohorts.
For the THA sub-group, a moderate, positive, statisti-
cally significant correlation existed between OHS and
EQ-5D VAS assessed at 6 months post-operatively (r(59)
= 0.39, p = 0.002), and a non-statistically significant
small, positive correlation was found between OKS and
EQ-5D VAS assessed at the same time point for the
Table 5 Final prognostic model for post-operative day 2 functional recovery (POD 2 mILAS) in overall cohort
Prognostic factors Unstandardized regression
coefficient (B)
Standard error of the
coefficient (SEB)
95% CI for B Standardized
coefficient (ß)
p value
Constant/intercept − 0.906 2.550 − 5.923, 4.111 0.723
Age 0.201 0.032 0.138, 0.264 0.297 < 0.001
Gender (0 = female, 1 = male) − 1.671 0.571 − 2.795, − 0.547 − 0.134 0.004
Pre-operative patient-reported general health
(EQ-5D VAS/100)
− 0.051 0.020 − 0.090, − 0.013 − 0.126 0.009
Pre-operative function (TUG, sec) 0.453 0.094 0.269, 0.637 0.241 < 0.001
Arthroplasty site (0 = THA, 1 = TKA) 2.223 0.631 0.982, 3.464 0.167 < 0.001
Anaesthetic—use of GA only − 2.067 0.674 − 3.392, − 0.742 − 0.148 0.002
Initial analgesia—LIA use − 3.022 0.848 − 4.690, − 1.355 − 0.184 < 0.001
Initial analgesia—PCA use 2.021 0.765 0.516, 3.526 0.134 0.009
Statistical significance assessed at the 0.05 level
CI confidence interval, EQ-5D VAS EuroQol-5 Dimension Visual Analogue Scale, GA general anaesthesia, LIA local infiltration analgesia, PCA patient-controlled
analgesia, TUG Timed Up and Go test, VAS visual analogue scale
Table 6 Final prognostic model for post-operative day 2 functional recovery (POD 2 mILAS) for the TKA group
Prognostic factors Unstandardized regression
coefficient (B)
Standard error of the
coefficient (SEB)
95% CI for B Standardized
coefficient (ß)
p value
Constant/intercept 7.837 4.187 − 0.415, 16.090 0.063
Age 0.184 0.042 0.101, 0.267 0.263 < 0.001
Gender (0 = female, 1 = male) − 1.487 0.696 − 2.859, − 0.116 − 0.120 0.034
Pre-operative patient-reported general health
(EQ-5D VAS/100)
− 0.087 0.024 − 0.134, − 0.039 − 0.207 < 0.001
Pre-operative function (TUG, sec) 0.503 0.114 0.279, 0.728 0.263 < 0.001
Surgery duration (min) − 0.033 0.016 − 0.064, − 0.002 − 0.125 0.038
Anaesthetic method: use of GA only − 2.066 0.858 − 3.756, − 0.375 − 0.143 0.017
Initial analgesia: LIA use − 3.619 1.193 − 5.971, − 1.267 − 0.179 0.003
Initial analgesia: PCA use 2.345 0.959 0.455, 4.235 0.154 0.015
Statistical significance assessed at the 0.05 level
CI confidence interval, EQ-5D VAS EuroQol-5 Dimension Visual Analogue Scale, GA general anaesthesia, LIA local infiltration analgesia, PCA patient-controlled
analgesia, TUG Timed Up and Go test, VAS visual analogue scale
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TKA sub-group (r(116) = 0.16, p = 0.093). 44.1% of the
overall sub-group reported health conditions unrelated
to the arthroplasty undertaken during the study im-
pacted their EQ-5D VAS assessed at 6 months post-
operatively.
LOS
LOS ranged from 2 to 16 days across all participants,
with a median LOS of 4 days for the overall cohort, and
for each of the THA and TKA groups. Statistically sig-
nificant correlations were found between multiple fac-
tors and LOS (Table 10). Patient-related factors that
were significantly positively correlated with LOS in-
cluded age, ASA grade, and pre-operative TUG time,
10mWT time, and mILAS score. Those significantly
negatively correlated with LOS were pre-operative RAPT
score, EQ-5D VAS, and OKS/OHS scores (Table 10).
Surgical and post-operative factors significantly posi-
tively correlated with LOS included incidence of post-
operative progress barriers and POD 2 mILAS, TUG,
and 10mWT scores (Table 10). THA (rather than TKA)
surgery, DAA or DSA (rather than PA) THA, use of GA
alone, combined use of GA and spinal anaesthesia, intra-
operative LIA use, and DOS mobilisation were all associ-
ated with shorter LOS than their alternatives (Table 10).
Discussion
This study assessed the strengths of the prognostic rela-
tionships between patient-related and surgical variables
and inpatient functional recovery (as assessed by POD 2
mILAS score) and yielded prognostic models for in-
patient functional recovery following THA and TKA. In
addition, patient-related, surgical, and post-operative
factors associated with hospital LOS were identified, and
the relationships between inpatient functional outcomes
and longer-term (6-month) patient-reported functional
outcomes were assessed. Overall, the findings indicate
that a range of patient-related factors assessed pre-
operatively as well as surgical and post-operative factors
were associated with inpatient functional outcomes and
with LOS following THA and TKA. In addition, longer-
term functional outcomes for these patients reflected
their inpatient functional outcomes. These findings ad-
dress a gap in the existing evidence base, highlight the
importance of assessing and optimising functional out-
comes in the inpatient period, and may usefully inform
the further development of ERP employed for THA and
TKA.
The final prognostic models for both the overall co-
hort and TKA group explained approximately one third
of the variance in inpatient functional recovery. Both
models included as significant prognostic factors patient
age, sex, pre-operative patient-reported general health,
pre-operative function (TUG), and GA, LIA, and PCA
use. In addition to these factors, arthroplasty site was a
prognostic factor for the overall cohort, and surgery dur-
ation was prognostic for the TKA group. The final prog-
nostic model for the THA group differed, possibly due
in part to the smaller number of THA participants in
the overall cohort, and included pre-operative function
(TUG time), RAPT score, and surgical approach. Again,
the prognostic model developed for the THA group ex-
plained approximately one third of the variance in in-
patient functional recovery. Importantly, noted in each
of the models was the contribution of both patient-
related and surgical factors. This is the first study, to our
knowledge, to identify independent, potentially modifi-
able surgical factors prognostic for early functional re-
covery following TKA or THA. The recent systematic
Table 7 Final prognostic model for post-operative day 2 functional recovery (POD 2 mILAS) for the THA group
Prognostic actors Unstandardized regression
coefficient (B)
Standard error of the
coefficient (SEB)
95% CI for B Standardized
coefficient (ß)
p value
Constant/intercept 17.614 3.824 10.031, 25.196 < 0.001
RAPT score (/12) − 0.943 0.278 − 1.493, − 0.392 − 0.314 0.001
Pre-operative function (TUG, sec) 0.357 0.160 0.039, 0.674 0.205 0.028
Surgical approach (0 = PA, 1 = DAA or DSA) − 4.671 1.016 − 6.686, − 2.656 − 0.373 < 0.001
Statistical significance assessed at the 0.05 level
CI confidence interval, DAA direct anterior approach, DSA direct superior approach, PA posterior approach, RAPT Risk Assessment and Prediction Tool, THA total
hip arthroplasty, TUG Timed Up and Go test
Table 8 Symptoms reported in medical records as impacting
post-operative progress in overall cohort
Progress barriers N (%)
Pain 100 (28.2%)
Nausea 47 (13.3%)
Dizziness/low BP/pre-syncope 53 (15.0%)
Drowsiness/fatigue 22 (6.2%)
Delirium/impulsiveness 14 (4.0%)
Wound ooze 12 (3.4%)
Anxiety 12 (3.4%)
Constipation 12 (3.4%)
Quads inhibition 9 (2.5%)
Other (including systemically unwell or
medical condition unrelated to surgery)
25 (7.1%)
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review conducted by Hewlett-Smith et al. [9] did not
find evidence that any individual surgical factors (other
than site of arthroplasty) were prognostic for early func-
tional recovery following THA or TKA.
In the prognostic models for both the overall cohort
and TKA group, LIA use was associated with greater
functional recovery and had the greatest prognostic
value in both of these models, whereas PCA use had a
negative impact on predicted POD2 mILAS scores. LIA
is thought to provide effective early post-operative anal-
gesia (without motor blockade), with less incidence of
post-operative complications such as nausea, and a
lower requirement for supplemental oral opioids; how-
ever, there is only low-level evidence for these effects in
THA [37] and TKA [38]. In addition, optimal volume,
composition, and site of administration of LIA have not
been confirmed [5]. Limiting use of PCA pumps in the
routine arthroplasty population is strongly recom-
mended due to associated functional impedance [5]. Al-
though attachments were routinely removed by POD 2
in the current study, PCA use was significantly corre-
lated with post-operative nausea (p < 0.001) and dizzi-
ness (p = 0.018) in the overall cohort, which may explain
its association with reduced functional recovery.
Less expected was the association between GA use
and greater functional recovery in the overall cohort and
TKA group. ERP literature has traditionally supported
the use of spinal anaesthesia [4, 39, 40], although a
meta-analysis of 29 studies including 10,488 patients re-
ported no significant difference in the incidence of peri-
operative complications following THA and TKA when
comparing neuraxial and general anaesthesia [41]. How-
ever, neuraxial methods were employed in significantly
fewer patients than GA, and notably, epidural rather
than spinal anaesthesia was the primary mode of neurax-
ial anaesthesia used [41]. Recently published anaesthesia
consensus guidelines have reported low evidence for pri-
mary TKA and low to moderate evidence for primary
THA in favour of neuraxial anaesthesia versus GA [42].
However, lack of detailed information regarding the
potentially wide variability in GA technique, in addition
to the significant evolution in GA, and the potential in-
fluence of modern GA technique on outcomes were also
acknowledged [42].
Surprisingly, longer surgery duration was prognostic of
greater recovery for the TKA group. It was, however,
found to have the least prognostic value in this model.
As surgery duration may be influenced by multiple fac-
tors including surgeon experience, anaesthetic tech-
nique, surgical approach, surgical technique, and
complexity of surgical procedure, the clinical relevance
of this particular finding is unclear.
In contrast, surgical approach was strongly prognostic
of greater inpatient functional recovery in the THA
group, making a difference of 4.7 points on the 36-point
mILAS scale. This may be due to the muscle-sparing na-
ture of the DAA and DSA compared to the PA THA,
for which inpatient functional recovery was poorer. A
systematic review [43] confirms that few studies have
compared THA surgical approaches using inpatient
function as an outcome. Achievement of early post-
operative functional goals has been reported in favour of
DAA compared to PA THA [16, 44, 45]. Recent guide-
lines, however, found inconclusive evidence regarding
the effect of different surgical approaches on time to
meet discharge criteria following THA in an enhanced
recovery setting; adequately powered randomised con-
trolled trials were recommended [5, 8]. Presently, this
study valuably adds to the evidence available to inform
practice in this area. Overall, with regard to surgical fac-
tors, our results indicate that DAA or DSA for THA, use
of GA only, and LIA use were all associated with greater
levels of post-operative functional recovery on POD 2,
and thus warrant consideration as key ERP components.
With respect to site of arthroplasty, a statistically sig-
nificant difference in POD2 mILAS scores was found in
favour of the THA group; however, this may be, in part,
due to the significant difference identified in ASA grade
distributions between the TKA and THA groups.
Although the THA group had lower pre-operative
Table 9 Differences in pre-operative and longer-term (6 months post-operative) patient-reported outcome measures
Patient-reported outcome measure Baseline score
Median (IQR)
Range, n






Change score exceeded MIC
At group levelb, n (%)
For individualsc, n (%)
OHS 22.0 (17.25, 29.0)
5–39, n = 60
46.0 (44.0, 48.0)
22–48, n = 61
22.5 (16.0, 28.75)
1–42, n = 60
60 (100%)
56 (93.3%)
OKS 25.0 (19.0, 32.0)
7–42, n = 117
43.0 (38.75, 46.0)
26-48, n = 118
16.0 (9.5, 23.0)
− 4.0–41.0, n = 117
117 (100%)
97 (82.9%)
EQ-5D VAS 80.0 (70.0, 90.0)
25–100, n = 178
85.0 (75.0, 90.0)
10–100, n = 179
1.0 (− 5.0, 12.5)
− 75–50, n = 178
N/A
EQ-5D VAS EuroQol-5 Dimension Visual Analogue Scale, IQR inter-quartile range, MIC minimal important change, OHS Oxford Hip Score, OKS Oxford Knee Score
aChange score is the difference between pre-operative baseline score and 6months post-operative score
bFor assessment at the group level, an MIC of 11 and 9 points was used for the OHS and OKS, respectively (Beard et al. [28])
cFor assessment of individual patients, an MIC of 8 and 7 points was used for the OHS and OKS, respectively (Beard et al. [28])
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Table 10 Association between individual potential prognostic factors and length of stay in overall cohort
Potential prognostic factors rS or U, Z values
IQR LOS (nights) for groups
p value
Patient-related factors
Gender (0 = female, 1 = male) 14685.0, − 1.022
IQR female (4.0–5.0), IQR male (4.0–5.0)
0.31
Age 0.20 < 0.001**
BMI 0.06 0.29
ASA 0.12 0.03*
Hb − 0.03 0.54
Living situation 0.04 0.51
RAPT score − 0.27 < 0.001**
Pre-op pain (VAS) 0.08 0.15
Pre-op patient-reported general health (EQ-5D VAS) − 0.11 0.03*
Pre-op patient-reported function (OKS/OHS) − 0.18 0.001**
Pre-op function (mILAS) 0.20 < 0.001**
Pre-op function (TUG) 0.26 < 0.001**
Pre-op function (10mWT) 0.21 < 0.001**
Surgical factors
Arthroplasty site (0 = THA, 1 = TKA) 12065.0, − 1.996
IQR THA (3.0–5.0), IQR TKA (4.0–5.0)
0.05*
Robot-assisted surgery (0 = no, 1 = yes) 5337.0, − 0.690
IQR no (4.0–5.0), IQR yes (3.25–5.0)
0.49
GA only (0 = no, 1 = yes) 10172.5, − 2.769
IQR no (4.0–5.0), IQR yes (3.0–5.0)
0.006**
GA and spinal anaesthesia (0 = no, 1 = yes) 13215.0, − 2.419
IQR no (3.0–5.0), IQR yes (4.0–5.0)
0.02*
Sedation and spinal anaesthesia (0 = no, 1 = yes) 7972.0, − 0.373
IQR no (4.0–5.0), IQR yes (4.0–5.0)
0.71
LIA use (0 = no, 1 = yes) 7150.0, − 2.398
IQR no (4.0–5.75), IQR yes (4.0–5.0)
0.02*
PCA use (0 = no, 1 = yes) 9709.0, − 1.122
IQR no (4.0–5.0), IQR yes (4.0–6.0)
0.26
Intra-articular catheter (TKA only) (0 = no, 1 = yes) 6671.0, − 0.755
IQR no (4.0–5.0), IQR yes (4.0–5.0)
0.45
Single-shot regional block (TKA only) (0 = no, 1 = yes) 2566.5, − 1.867
IQR no (4.0–5.0), IQR yes (4.0–6.0)
0.06
Ambulatory regional block (TKA only) (0 = no, 1 = yes) 2437.0, − 0.720
IQR no (4.0–5.0), IQR yes (3.0–5.5)
0.47
Surgical approach (THA only) (0 = PA, 1 = DAA or DSA) 975.5, − 3.645
IQR PA (4.0–5.0), IQR DAA or DSA (3.0–4.0)
< 0.001**
Surgery duration − 0.03 0.52
Tourniquet duration (TKA only) − 0.02 0.94
Tourniquet pressure (TKA only) − 0.02 0.50
Post-operative factors
DOS mobilisation (0 = no, 1 = yes) 10,659.0−2.443
IQR no (4.0–6.0), IQR yes (4.0–5.0)
0.02*
Incidence of post-operative progress barriers (0 = no, 1 = yes) 8482.5, − 7.735
IQR no (3.0–4.0), IQR yes (4.0–6.0)
< 0.001**
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comorbidity overall (Table 1), both arthroplasty groups
had a median ASA grade of 2. Additionally, the THA
group had a greater proportion of patients receiving
GA only (also a significant prognostic factor for POD
2 mILAS scores); however, site of arthroplasty and
use of GA only were both significant independent
prognostic factors within the final prognostic model
for the overall cohort. Few studies have investigated
site of arthroplasty as a prognostic factor for early
post-operative functional outcomes. Although meth-
odological quality limited the generalisability of the
results, significantly slower functional recovery was
observed in TKA patients when compared to THA
patients at 1 week post-operatively [46, 47].
Interestingly, several potentially modifiable patient-
related factors were significantly prognostic for POD 2
mILAS scores. These include pre-operative TUG time,
RAPT score, and self-reported general health status
(EQ-5D VAS). TUG time was the only prognostic factor
to feature in each of the final models. Findings for the
overall cohort indicate that every 5-s increase in time to
complete the pre-operative TUG test equates to an in-
crease of 2.25 points in the mean predicted POD 2
mILAS score, representing poorer functional recovery.
This finding is relevant particularly for patients of lower
pre-operative functional status and supports the avail-
able evidence for pre-operative conditioning. The
prognostic value of pre-operative TUG time, specific-
ally, has been supported by a strong level of evidence
in TKA studies, but only limited evidence in studies
of THA [9]. A further study, not included in the sys-
tematic review [9], also reported pre-operative TUG
time in their final predictive model for functional re-
covery following THA [16].
Higher RAPT scores were strongly prognostic of
greater POD 2 functional recovery in the THA model,
such that a difference of 5 points on the RAPT would be
associated with a mILAS difference of 4.7 points (equal
to that associated with a change in THA surgical ap-
proach). Developed as a screening tool to predict dis-
charge destination following THA and TKA, the RAPT
score assigns values to the patient’s age, sex, pre-
operative exercise tolerance, the necessity for a mobility
aid or community services, and social support upon dis-
charge [48]. Although the RAPT score is primarily deter-
mined by non-modifiable factors, scoring of the exercise
tolerance item and potentially the mobility aid item may
be improved by optimising pre-operative function. The
RAPT has only been identified in one other study as a
potential predictor for early functional recovery [16] and
was not included in their final prediction model.
Pre-operative patient-reported general health status
had limited prognostic value in the models for both the
overall cohort and TKA group. As expected, poorer pre-
operative general health was associated with lower levels
of post-operative functional recovery; however, a differ-
ence of 20 points on the EQ-5D VAS would be required
to effect a change of 1.0 and 1.8 points in mILAS score
for the overall cohort and TKA group, respectively. Fur-
thermore, only a weak, statistically significant positive
correlation was identified between ASA grade and POD
2 mILAS scores. This finding is in contrast with the
strong and moderate levels of evidence for TKA and for
THA, respectively, previously reported for an association
between comorbidity status (ASA grade) and early post-
operative functional outcomes [9].
Slower functional recovery was apparent for patients
of older age and female sex in the overall cohort and
TKA group. To date, two systematic reviews [9, 49] have
reported conflicting evidence regarding an association
between age and early post-operative functional recovery
following THA [9, 49] and TKA [9]. Similarly, conflict-
ing evidence was found for sex [9, 49] in studies of
THA, whilst limited evidence supported an association
between female sex and reduced early post-operative
functional recovery in TKA studies [9].
Taken together, the identification of these patient-
related prognostic factors supports pre-operative screen-
ing to identify patients of older age, female sex, poorer
pre-operative health and functional status, and scoring
lower on the RAPT as they may be less likely to achieve
an accelerated recovery per many ERP. The use of these
Table 10 Association between individual potential prognostic factors and length of stay in overall cohort (Continued)
Potential prognostic factors rS or U, Z values
IQR LOS (nights) for groups
p value
POD 2mILAS 0.54 < 0.001**
POD 2 TUG 0.31 < 0.001**
POD 2 10mWT 0.28 < 0.001**
p values were derived from Spearman’s correlation or Mann-Whitney U test, as appropriate for variable type
ASA American Society of Anaesthesiologists, BMI body mass index, DAA direct anterior approach, DSA direct superior approach, DOS day of surgery, EQ-5D VAS
EuroQol-5 Dimension Visual Analogue Scale, GA general anaesthesia, Hb haemaglobin, IQR inter-quartile range, LIA local infiltration analgesia, LOS length of stay,
mILAS modified Iowa Level of Assistance Scale, OKS Oxford Knee Score, OHS Oxford Hip Score, PA posterior approach, PCA patient-controlled analgesia, POD post-
operative day, RAPT Risk Assessment and Prediction Tool, THA total hip arthroplasty, TKA total knee arthroplasty, TUG Timed Up and Go test, VAS visual analogue
scale, 10mWT ten-metre walk test
*Statistical significance p < 0.05 level
**Statistical significance p < 0.01 level
Hewlett-Smith et al. Journal of Orthopaedic Surgery and Research          (2020) 15:360 Page 14 of 19
prognostic models during pre-operative screening may
facilitate organisational efficiency by assisting in the pre-
diction of patient flow. Telehealth may be a viable op-
tion for pre-operative screening in patients with reduced
access to services [50] and avoids a significant cost bur-
den to both patients and healthcare organisations [51].
Prehabilitation may significantly impact pre-operative
TUG time, as well as exercise tolerance, thus potentially
improving RAPT score and general well-being. As per
the prognostic model, improvement in pre-operative
function would result in changes to predicted early post-
operative functional recovery.
Few studies, to our knowledge, have linked inpatient
post-operative function to longer-term outcomes. Our
results are similar to Bade et al. [18] who found acute
functional performance to be predictive of functional
performance at 6 months post-operatively following
TKA, although pre-operative functional performance
was found to be a stronger predictor. The small associ-
ation between POD 2 mILAS scores and patient-
reported functional outcomes assessed via OKS and
OHS at 6 months post-operatively found for the overall
cohort and the TKA sub-group warrants further re-
search with larger cohorts. Inpatient function does not
appear to be associated with longer-term general health.
However, the EQ-5D VAS requires the respondent to
rate their health “today”, thus providing a very specific
“snap-shot” of health status, which may be influenced by
numerous factors. In addition, although a positive cor-
relation existed between 6months post-operative OHS
and OKS scores and EQ-5D VAS assessed at the same
time, 44.1% of the overall sub-group reported health
conditions other than the arthroplasty undertaken dur-
ing the study impacted their EQ-5D VAS. Moreover,
general health ratings remained largely static pre-
operatively to post-operatively despite large improve-
ments in joint-specific functional assessments (OHS and
OKS).
Inpatient functional performance was significantly cor-
related with LOS in the overall cohort, and similar re-
sults have been reported by Poitras et al. [15]. Higher
POD 2 mILAS scores may be a useful clinical indicator
of patients at risk of prolonged LOS, enabling prompt
post-operative planning for patients who are recovering
function more slowly than expected. Weak correlations
between all patient-related factors and LOS were identi-
fied in this study. This is in contrast to previously re-
ported strong level evidence for higher ASA grade,
greater number of comorbidities, and presence of heart
or lung disease as predictors of longer LOS following
THA [49]. THA surgical approach was the only surgical
factor in this study to be moderately correlated with
LOS. PA THA was associated with longer LOS than
DAA or DSA. A study of 5341 THA procedures also
found patients who received DAA or DSA THA had sta-
tistically significantly shorter LOS and a higher rate of
discharge directly home [52].
Strengths of this study include the spectrum of pa-
tient and surgical prognostic factors and the use of
standardised, validated functional performance mea-
sures which are clinically relevant, easily integrated
into routine post-operative assessment, and appropri-
ate to the time point at which they were assessed.
The mILAS [11] was selected as the primary out-
come measure as it incorporates tasks reflective of
the ADL necessary to safely discharge home [53].
Versions of the mILAS have been used in similar
studies; however, its implementation is heteroge-
neous and has thus limited the comparison of re-
sults. The study cohort is believed to be reflective of
the general arthroplasty population, with few exclu-
sion criteria implemented. To control for the poten-
tial influence of patient expectation on LOS, only
patients who attended pre-admission clinic and re-
ceived pre-operative education were included in the
study.
There are several limitations of this study. The prog-
nostic models are based on data from a single centre
which has implemented a partially standardised ERP.
To increase generalisability, the models require in-
ternal and external validation preferably in a multi-
centre study, similarly involving non-standardised
ERP. POD 2 was chosen as the time point to assess
functional recovery to enable comparisons with stud-
ies examining ERP outcomes where a LOS of 2 days
has been reported. However, with THA and TKA be-
ing performed as ambulatory surgery in some organi-
sations, further studies with earlier post-operative
assessment time points are needed. While LIA use was
identified as a significant prognostic factor, variations
in site of administration, volume, and content of LIA
administered were not accounted for in this study.
Similarly, differences in dosage parameters, content,
or duration of PCA use were not addressed; thus, fur-
ther research is required to determine the impact of
these variables. The impact of robotic-assisted surgery
could not be fully assessed due to its application in
only a small volume of the study cohort. Currently, in
this facility, robot-assisted surgery is primarily used
for uni-compartmental knee arthroplasty which, to
maximise homogeneity, was not included in this co-
hort. Due to insufficient case numbers, the role of
muscle-sparing approaches for TKA was also not able
to be assessed; thus, these surgical factors warrant fur-
ther research. Further research is also necessary to de-
termine cut-off points for age, pre-operative TUG
time, pre-operative EQ-5D VAS, and RAPT score to
further guide pre-operative screening.
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Due to time constraints, only the first half of the
study cohort was assessed for longer-term functional
outcomes. Due to the natural evolution of enhanced
recovery techniques during the period of data collec-
tion, this sample may have varied slightly, with regard
to surgical factors, from the remainder of the cohort.
To reduce the potential for missing data, participants
were not required to attend the hospital for assess-
ment of longer-term functional outcomes. Therefore,
inpatient function and longer-term functional out-
comes could not be directly compared due to the
variance in outcome measures assessed. However, in-
patient function and longer-term functional outcomes
could both be directly compared to pre-operative
functional outcomes.
Validated tools for assessing short-term post-
operative function following lower limb arthroplasty
are lacking [11, 54]. In the absence of a gold standard
for evaluating functional recovery in acute hospital in-
patients, the mILAS [11] was used in this study.
However, a 30-point version of the mILAS has re-
cently been described and validated by Elings et al.
[55] which may be of greater clinical relevance as it
only assesses functional tasks. Implementation of a
valid, standardised performance measure, such as this
newer version of the mILAS, would assist in objective
assessment of post-operative functional recovery,
identification of patients at risk of prolonged LOS,
and evaluation of ERP interventions [54], and also fa-
cilitate the benchmarking of patient-centred outcomes
between organisations.
Conclusions
This study identified several patient-related and sur-
gical factors prognostic for early post-operative func-
tional recovery. Patient-related factors included in
the final prognostic models for the overall cohort
and TKA group were age, sex, pre-operative general
health status, and pre-operative TUG time. Pre-
operative TUG time and RAPT score were prognos-
tic in the final model for the THA group. Surgical
prognostic factors for the overall cohort and TKA
group were use of GA only, LIA use and PCA use,
with the addition of arthroplasty site in the model
for the overall cohort, and surgery duration in the
TKA group. Surgical approach was the only surgical
prognostic factor in the model for the THA group.
THA surgery was prognostic for greater functional
recovery at POD 2 than TKA surgery. Several
patient-related, surgical, and post-operative factors
were associated with acute hospital LOS. A correl-
ation was found between functional ability at POD 2
and OKS/OHS, assessed at 6 months post-
operatively. Validation of these findings is required,
and assessment time points earlier in the post-
operative period could be implemented. Prognostic
models may facilitate the prediction of inpatient flow
thus optimising organisational efficiency. In addition,
surgical prognostic factors warrant consideration as
potentially key ERP elements, associated with early
functional recovery. Standardised functional outcome
measures are needed to evaluate patient-centred ERP
outcomes and to facilitate the processes of bench-
marking, auditing, and improving ERP.
Appendix 1: Two-stage process for exclusion of
patients with cognitive impairment
1st stage: Pre-admission screening
Patients were screened by an occupational therapist
(OT) during their pre-admission interview. Initial cogni-
tive screening occurred via the OT’s observation of the
patient during the interview as well as the following
screening question. “Do you have any difficulties with
your thinking or memory?”
If a Yes response was elicited with the above cognitive
screening question:
The patient was flagged by the OT, and the Mini-
Mental State Examination (MMSE) [10] was imple-
mented by the patient’s treating physiotherapist on the
acute orthopaedic ward during hospital admission. Pa-
tients scoring 23 or less, out of a maximum possible
score of 30 (indicating cognitive impairment), were sub-
sequently excluded from the research study, and on that
basis, their data was not included in the data set or
analysis.
If a No response was elicited with the above cognitive
screening question:
The patient was considered eligible to consent to
participate in the research study. However, the OT
flagged any patients whom exhibited signs of cogni-
tive impairment during the interview despite answer-
ing “No” to the screening question, and the MMSE
was performed by the patient’s treating physiotherap-
ist on the acute orthopaedic ward during hospital ad-
mission. Patients scoring 23 or less were subsequently
excluded from the research study, and on that basis,
their data was not included in the data set or
analysis.
2nd stage: Noted poor post-operative progression
Any research study participant identified by their treat-
ing physiotherapist as not following a usual post-
operative recovery due to possible cognitive impairment
undertook an MMSE on the acute orthopaedic ward. Pa-
tients scoring 23 or less were subsequently excluded
from the research study, and on that basis, their data
was not included in the data set or analysis.
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Appendix 2
Table 11 Modified Iowa Level of Assistance Scale (Kimmel et al. [12])
Score Amount of
assistance
Items 1–4 Item 5 Item 6
0 Independent No assistance or supervision is necessary to safely perform the activity (with or
without an assistive device/aid)
> 40 m No assistive device
1 Standby Nearby supervision is required; no contact is necessary 26–40m 1 stick or crutch
2 Minimal One point of contact is necessary, including helping with the application of the
assistive device, getting legs on/off leg rest, and stabilising the assistive device
10–25m 2 sticks
3 Moderate Two points of contact needed (1–2 people) 5–9 m 2 elbow crutches
4 Maximal Significant support—3 or more points of contact (> 1 person) 3–4 m 2 axillary crutches
5 Failed Attempted activity but failed with maximal assistance 2 m Frame (standard or wheelie)
6 Not tested Test was not attempted due to medical reasons or reasons of safety < 2 m Gutter/platform frame, standing
lifter, hoist, or unsafe to use aid
Modified Iowa Level of Assistance Scale items: 1—supine to sitting on the edge of the bed, 2—sit to stand, 3—walking, 4—negotiation of one step, 5—walking
distance, 6—assistive device used
Appendix 3
Table 12 The Wesley Hospital Enhanced Recovery Pathway
(ERP) discharge criteria for THA and TKA
Allied health Independent with transfers in/out of bed and chair
Walking independently with aid
Able to negotiate stairs (with supervision, if needed)




Wound and dressings reviewed (as appropriate)
Discharge Planning (e.g. services organised if
applicable, support person contacted)
Patient Accepting of discharge plan
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